$IDRA Headlines 4 stocks to watch 3:42 p.m. Ma
Post# of 74540
Posted On: 06/24/2014 9:41:42 AM
$IDRA Headlines
4 stocks to watch 3:42 p.m. March 19, 2014 - The Trading Deck
Charting the backdrop ahead of the Fed 11:13 a.m. March 19, 2014 - Michael Ashbaugh
Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
S&P 500 rattles the cage on latest all-time high 12:28 p.m. Feb. 24, 2014 - Michael Ashbaugh
Bears chip away at the S&P 1,775 support 12:01 p.m. Feb. 3, 2014 - Michael Ashbaugh
Charting a bullish early-2014 outlook 1:05 p.m. Dec. 31, 2013 - Michael Ashbaugh
Charting a bullish early-2014 outlook 12:39 p.m. Dec. 31, 2013 - Michael Ashbaugh
S&P, Nasdaq rally from major support 12:09 p.m. Dec. 16, 2013 - Michael Ashbaugh
Pfizer, Affymetrix weigh on drug stocks 3:04 p.m. July 7, 2011 - Val Brickates Kennedy
Idera tumbles 14% on drug setback 2:52 p.m. July 7, 2011 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 5:37 p.m. Jan. 19, 2010 - MarketWatch
Incyte, Idera move on Novartis deals 3:02 p.m. Nov. 25, 2009 - Val Brickates Kennedy
Novartis terminates pact with Idera 9:28 a.m. Nov. 25, 2009 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 5:29 p.m. Dec. 26, 2007 - MarketWatch
Idera Pharmaceuticals' president, Karr, resigns 10:08 a.m. Dec. 26, 2007 - Robert Daniel
Idera Pharma President Karr resigns, stays on board 10:03 a.m. Dec. 26, 2007 - Robert Daniel
Idera signs agonist licensing, collaboration with Merck KGaA 8:10 a.m. Dec. 19, 2007 - Sarah Turner
Idera to get up to $381 mln in milestones 8:03 a.m. Dec. 19, 2007 - Steve Goldstein
Idera, Merck KGaA agree collaboration deal 8:02 a.m. Dec. 19, 2007 - Steve Goldstein
Wednesday's biggest stock gainers and decliners 7:03 p.m. Feb. 28, 2007 - Michael Baron
Insider Buying On The Rise At These 5 Stocks With Earnings Next Week 4:33 p.m. May 8, 2014 - TheStreet.com
Abbott to develop molecular diagnostic test for Indera 9:01 a.m. May 8, 2014 - Seeking Alpha
Will Idera Pharmaceuticals (IDRA) Stock Sustain Today's Rally? 1:21 p.m. April 22, 2014 - TheStreet.com
Interesting IDRA Put And Call Options For June 21st 1:11 p.m. April 22, 2014 - TheStreet.com
Today's Dead Cat Bounce Stock Is Idera Pharmaceuticals (IDRA) 10:10 a.m. April 11, 2014 - TheStreet.com
Idera +5% AH on positive IMO-8400 data 5:24 p.m. April 7, 2014 - Seeking Alpha
Idera Soars on Phase II Drug Data - Analyst Blog 5:06 p.m. March 31, 2014 - Zacks.com
Idera up big premarket 9:11 a.m. March 28, 2014 - Seeking Alpha
Idera slumps 4:21 p.m. March 24, 2014 - Seeking Alpha
Idera: A Compelling Biotech Pick For March 11:34 a.m. March 7, 2014 - Seeking Alpha
3 Small Cap Biotechs With Near-Term Catalysts 10:25 a.m. March 6, 2014 - Seeking Alpha
Idera Pharmaceuticals: Set To Ride A 200% Gain In 2014 10:38 a.m. Jan. 31, 2014 - Seeking Alpha
Idera Pharmaceuticals Presents a Promising Opportunity 3:23 p.m. Dec. 26, 2013 - Wall St. Cheat Sheet
Friday’s Biggest Stock Losers: INSY OPK, and More 8:52 a.m. Dec. 13, 2013 - InvestorPlace.com
9 Biotechnology Stocks to Buy Now 7:00 a.m. Dec. 11, 2013 - InvestorPlace.com
10-Q: IDERA PHARMACEUTICALS, INC. 8:02 a.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Biotech-Focused Baker Bros. Accumulates These 3 Stocks 9:55 a.m. Oct. 1, 2013 - Seeking Alpha
Idera Phase 2 Data Provides For Exciting Q4 2013 And Q1 2014 9:02 a.m. Sept. 25, 2013 - Seeking Alpha
Analysts: Blackstone Mortgage Gaining Traction and 3 Other Research Notes to Browse 2:37 p.m. Aug. 29, 2013 - Wall St. Cheat Sheet
10-Q: IDERA PHARMACEUTICALS, INC. 7:49 a.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
Idera Pharmaceuticals to Participate in a Panel Discussion at the Piper Jaffray GenomeRx Symposium 8:00 a.m. June 17, 2014 - BusinessWire - BZX
Idera Pharmaceuticals to Present at the Nucleic Acid Summit 2014 4:25 p.m. June 13, 2014 - BusinessWire - BZX
Morning Briefing on Top Gainers -- Research on GTx Inc., Iridium Communications, Neuralstem, and Idera Pharma 6:50 a.m. May 29, 2014 - PR Newswire - PRF
Idera Pharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference 8:31 a.m. May 28, 2014 - BusinessWire - BZX
Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Idera Pharmaceuticals Reports First Quarter 2014 Financial Results and Provides Update on Key Programs and Business Strategy 7:01 a.m. May 13, 2014 - BusinessWire - BZX
Idera Announces Agreement with Abbott to Develop a Companion Diagnostic for IMO-8400 in Genetically Defined Forms of B-cell Lymphoma 8:31 a.m. May 8, 2014 - BusinessWire - BZX
Pre-market Biotech Picks -- Research on Dendreon, Keryx Biopharma, Idera Pharma, and Vertex Pharma 8:00 a.m. May 7, 2014 - PR Newswire - PRF
Idera Pharmaceuticals to Host Conference Call and Webcast to Report First Quarter 2014 Financial Results and Provide a Detailed Pipeline Review 8:31 a.m. May 6, 2014 - BusinessWire - BZX
Idera Expands Management Team with Three Key Hires 8:31 a.m. May 5, 2014 - BusinessWire - BZX
U.S. District Court Judge Nixes Banning of Zogenix's Painkiller in Massachusetts 10:42 a.m. April 21, 2014 - ACCESSWIRE
Top Gainers Technical Data -- Research on BioScrip, E-House China Holdings, MagneGas, and Idera Pharma 8:47 a.m. April 9, 2014 - PR Newswire - PRF
Idera Presents Preclinical Data at AACR Showing IMO-8400 Inhibits Tumor Growth and Survival Signaling in B-cell Lymphoma Cells with Oncogenic MYD88 L265P Mutation 4:06 p.m. April 7, 2014 - BusinessWire - BZX
Patient Enrollment, Acquisitions, FDA Reviews, and Results of Earnings and Clinical Trials - Analyst Notes on Arrowhead, Providence, Durata, Orthofix, and Idera 8:00 a.m. April 4, 2014 - PR Newswire - PRF
BlackBerry Wins Preliminary Injunction against Ryan Seacrest's Typo Products; Red Hat Tumbles on Weak Guidance 12:17 a.m. March 31, 2014 - ACCESSWIRE
Idera Pharmaceuticals Announces Positive Top-line Data in Phase 2 Trial of IMO-8400 7:15 a.m. March 28, 2014 - BusinessWire - BZX
New Highs & Stocks to Watch -- Research on Penn Virginia, Idera Pharma, US Geothermal, and First Republic Bank 8:23 a.m. March 19, 2014 - PR Newswire - PRF
Idera Pharmaceuticals Reports Fourth Quarter and Year End 2013 Financial Results and Provides Corporate Update 7:51 a.m. March 13, 2014 - BusinessWire - BZX
Idera Pharmaceuticals Announces Expansion of Pipeline into Two Orphan Autoimmune Diseases 7:35 a.m. March 13, 2014 - BusinessWire - BZX
Idera Pharmaceuticals Announces Appointment of Julian Baker and Dr. Kelvin Neu to its Board of Directors 8:31 a.m. March 12, 2014 - BusinessWire - BZX
4 stocks to watch 3:42 p.m. March 19, 2014 - The Trading Deck
Charting the backdrop ahead of the Fed 11:13 a.m. March 19, 2014 - Michael Ashbaugh
Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
S&P 500 rattles the cage on latest all-time high 12:28 p.m. Feb. 24, 2014 - Michael Ashbaugh
Bears chip away at the S&P 1,775 support 12:01 p.m. Feb. 3, 2014 - Michael Ashbaugh
Charting a bullish early-2014 outlook 1:05 p.m. Dec. 31, 2013 - Michael Ashbaugh
Charting a bullish early-2014 outlook 12:39 p.m. Dec. 31, 2013 - Michael Ashbaugh
S&P, Nasdaq rally from major support 12:09 p.m. Dec. 16, 2013 - Michael Ashbaugh
Pfizer, Affymetrix weigh on drug stocks 3:04 p.m. July 7, 2011 - Val Brickates Kennedy
Idera tumbles 14% on drug setback 2:52 p.m. July 7, 2011 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 5:37 p.m. Jan. 19, 2010 - MarketWatch
Incyte, Idera move on Novartis deals 3:02 p.m. Nov. 25, 2009 - Val Brickates Kennedy
Novartis terminates pact with Idera 9:28 a.m. Nov. 25, 2009 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 5:29 p.m. Dec. 26, 2007 - MarketWatch
Idera Pharmaceuticals' president, Karr, resigns 10:08 a.m. Dec. 26, 2007 - Robert Daniel
Idera Pharma President Karr resigns, stays on board 10:03 a.m. Dec. 26, 2007 - Robert Daniel
Idera signs agonist licensing, collaboration with Merck KGaA 8:10 a.m. Dec. 19, 2007 - Sarah Turner
Idera to get up to $381 mln in milestones 8:03 a.m. Dec. 19, 2007 - Steve Goldstein
Idera, Merck KGaA agree collaboration deal 8:02 a.m. Dec. 19, 2007 - Steve Goldstein
Wednesday's biggest stock gainers and decliners 7:03 p.m. Feb. 28, 2007 - Michael Baron
Insider Buying On The Rise At These 5 Stocks With Earnings Next Week 4:33 p.m. May 8, 2014 - TheStreet.com
Abbott to develop molecular diagnostic test for Indera 9:01 a.m. May 8, 2014 - Seeking Alpha
Will Idera Pharmaceuticals (IDRA) Stock Sustain Today's Rally? 1:21 p.m. April 22, 2014 - TheStreet.com
Interesting IDRA Put And Call Options For June 21st 1:11 p.m. April 22, 2014 - TheStreet.com
Today's Dead Cat Bounce Stock Is Idera Pharmaceuticals (IDRA) 10:10 a.m. April 11, 2014 - TheStreet.com
Idera +5% AH on positive IMO-8400 data 5:24 p.m. April 7, 2014 - Seeking Alpha
Idera Soars on Phase II Drug Data - Analyst Blog 5:06 p.m. March 31, 2014 - Zacks.com
Idera up big premarket 9:11 a.m. March 28, 2014 - Seeking Alpha
Idera slumps 4:21 p.m. March 24, 2014 - Seeking Alpha
Idera: A Compelling Biotech Pick For March 11:34 a.m. March 7, 2014 - Seeking Alpha
3 Small Cap Biotechs With Near-Term Catalysts 10:25 a.m. March 6, 2014 - Seeking Alpha
Idera Pharmaceuticals: Set To Ride A 200% Gain In 2014 10:38 a.m. Jan. 31, 2014 - Seeking Alpha
Idera Pharmaceuticals Presents a Promising Opportunity 3:23 p.m. Dec. 26, 2013 - Wall St. Cheat Sheet
Friday’s Biggest Stock Losers: INSY OPK, and More 8:52 a.m. Dec. 13, 2013 - InvestorPlace.com
9 Biotechnology Stocks to Buy Now 7:00 a.m. Dec. 11, 2013 - InvestorPlace.com
10-Q: IDERA PHARMACEUTICALS, INC. 8:02 a.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Biotech-Focused Baker Bros. Accumulates These 3 Stocks 9:55 a.m. Oct. 1, 2013 - Seeking Alpha
Idera Phase 2 Data Provides For Exciting Q4 2013 And Q1 2014 9:02 a.m. Sept. 25, 2013 - Seeking Alpha
Analysts: Blackstone Mortgage Gaining Traction and 3 Other Research Notes to Browse 2:37 p.m. Aug. 29, 2013 - Wall St. Cheat Sheet
10-Q: IDERA PHARMACEUTICALS, INC. 7:49 a.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
Idera Pharmaceuticals to Participate in a Panel Discussion at the Piper Jaffray GenomeRx Symposium 8:00 a.m. June 17, 2014 - BusinessWire - BZX
Idera Pharmaceuticals to Present at the Nucleic Acid Summit 2014 4:25 p.m. June 13, 2014 - BusinessWire - BZX
Morning Briefing on Top Gainers -- Research on GTx Inc., Iridium Communications, Neuralstem, and Idera Pharma 6:50 a.m. May 29, 2014 - PR Newswire - PRF
Idera Pharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference 8:31 a.m. May 28, 2014 - BusinessWire - BZX
Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Idera Pharmaceuticals Reports First Quarter 2014 Financial Results and Provides Update on Key Programs and Business Strategy 7:01 a.m. May 13, 2014 - BusinessWire - BZX
Idera Announces Agreement with Abbott to Develop a Companion Diagnostic for IMO-8400 in Genetically Defined Forms of B-cell Lymphoma 8:31 a.m. May 8, 2014 - BusinessWire - BZX
Pre-market Biotech Picks -- Research on Dendreon, Keryx Biopharma, Idera Pharma, and Vertex Pharma 8:00 a.m. May 7, 2014 - PR Newswire - PRF
Idera Pharmaceuticals to Host Conference Call and Webcast to Report First Quarter 2014 Financial Results and Provide a Detailed Pipeline Review 8:31 a.m. May 6, 2014 - BusinessWire - BZX
Idera Expands Management Team with Three Key Hires 8:31 a.m. May 5, 2014 - BusinessWire - BZX
U.S. District Court Judge Nixes Banning of Zogenix's Painkiller in Massachusetts 10:42 a.m. April 21, 2014 - ACCESSWIRE
Top Gainers Technical Data -- Research on BioScrip, E-House China Holdings, MagneGas, and Idera Pharma 8:47 a.m. April 9, 2014 - PR Newswire - PRF
Idera Presents Preclinical Data at AACR Showing IMO-8400 Inhibits Tumor Growth and Survival Signaling in B-cell Lymphoma Cells with Oncogenic MYD88 L265P Mutation 4:06 p.m. April 7, 2014 - BusinessWire - BZX
Patient Enrollment, Acquisitions, FDA Reviews, and Results of Earnings and Clinical Trials - Analyst Notes on Arrowhead, Providence, Durata, Orthofix, and Idera 8:00 a.m. April 4, 2014 - PR Newswire - PRF
BlackBerry Wins Preliminary Injunction against Ryan Seacrest's Typo Products; Red Hat Tumbles on Weak Guidance 12:17 a.m. March 31, 2014 - ACCESSWIRE
Idera Pharmaceuticals Announces Positive Top-line Data in Phase 2 Trial of IMO-8400 7:15 a.m. March 28, 2014 - BusinessWire - BZX
New Highs & Stocks to Watch -- Research on Penn Virginia, Idera Pharma, US Geothermal, and First Republic Bank 8:23 a.m. March 19, 2014 - PR Newswire - PRF
Idera Pharmaceuticals Reports Fourth Quarter and Year End 2013 Financial Results and Provides Corporate Update 7:51 a.m. March 13, 2014 - BusinessWire - BZX
Idera Pharmaceuticals Announces Expansion of Pipeline into Two Orphan Autoimmune Diseases 7:35 a.m. March 13, 2014 - BusinessWire - BZX
Idera Pharmaceuticals Announces Appointment of Julian Baker and Dr. Kelvin Neu to its Board of Directors 8:31 a.m. March 12, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼